FILANA THERAPEUTICS, INC. (FLNA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-122.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$95.39M | -$141.45M | -$105.96M | -$80.02M | -$32.87M | -$6.45M | -$4.96M | -$6.66M | -$11.95M | -$14.96M |
| Net Income | -$90.97M | -$24.34M | -$97.22M | -$76.25M | -$32.38M | -$6.33M | -$4.63M | -$6.56M | -$11.91M | -$14.85M |
| EPS (Diluted) | $-1.88 | $-0.53 | $-2.32 | $-1.90 | $-0.82 | — | — | — | — | — |
| Total Assets | $118.36M | $157.53M | $151.66M | $234.83M | $266.78M | $94.30M | $23.49M | $20.14M | $10.83M | $19.30M |
| Total Liabilities | $43.95M | $11.83M | $14.20M | $7.29M | $12.87M | $2.10M | $1.39M | $511.0K | $1.13M | $665.0K |
| Shareholders' Equity | $74.40M | $145.70M | $137.47M | $227.54M | $253.91M | $92.20M | $22.10M | $19.63M | $9.70M | $18.64M |
| Cash & Equivalents | $95.50M | $128.57M | $121.14M | $201.01M | $233.44M | $93.51M | $23.08M | $19.81M | $10.48M | $16.61M |
| Operating Cash Flow | -$32.25M | -$116.93M | -$82.03M | -$77.51M | -$30.20M | -$5.38M | -$2.51M | -$4.77M | -$8.24M | -$12.23M |
| Capital Expenditures | $581.0K | $103.0K | $414.0K | $2.71M | $22.21M | — | $18.0K | — | — | $75.0K |
| Shares Outstanding | 48.31M | 48.20M | 42.24M | 41.74M | 40.02M | 35.24M | 21.84M | 17.22M | 6.60M | 6.59M |